Eur Rev Med Pharmacol Sci 2020; 24 (2): 481-482
DOI: 10.26355/eurrev_202001_20020

Current predictive pathology in the clinical setting of colorectal cancer

G. Toni, R. Franco, R. Di Francia

Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy. renato.franco@unicampania.it

Free PDF Download

To cite this article

G. Toni, R. Franco, R. Di Francia
Current predictive pathology in the clinical setting of colorectal cancer

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 2
Pages: 481-482
DOI: 10.26355/eurrev_202001_20020

Keywords Related articles:

  1. The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology
  2. Downregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients
  3. MiR-511-5p functions as a tumor suppressor and a predictive of prognosis in colorectal cancer by directly targeting GPR116
  4. The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology
  5. Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer